CONCENTRATIONS AND MOLECULAR-FORMS OF HUMAN BRAIN NATRIURETIC PEPTIDE IN PLASMA

被引:57
作者
TATEYAMA, H
HINO, J
MINAMINO, N
KANGAWA, K
MINAMINO, T
SAKAI, K
OGIHARA, T
MATSUO, H
机构
[1] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[2] MIYAZAKI MED COLL,DEPT BIOCHEM,MIYAZAKI 88916,JAPAN
[3] OSAKA UNIV,SCH MED,DEPT GERIATR MED,OSAKA 553,JAPAN
[4] SAKURABASHI WATANABE HOSP,KITA,OSAKA 532,JAPAN
关键词
D O I
10.1016/0006-291X(92)91691-I
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a highly sensitive radioimmunoassay (RIA) system for human brain natriuretic peptide (BNP), immunoreactive (ir-) human BNP was found to be present in plasma, in addition to heart and brain tissue. Plasma concentrations of ir-BNP were 0.17∼0.74 fmol/ml (mean: 0.35 fmol/ml) in normal young men, being about 1 17 of the plasma concentration of human atrial natriuretic peptide (ANP). In patients with heart disease, plasma concentration of ir-BNP increased about 100-fold (5.00∼177.37 fmol/ml), being nearly comparable to that of ir-ANP, even though ANP concentration also increased about 7-fold. Two molecular forms of ir-BNP in plasma were identified as BNP-32 and γ-BNP (pro-BNP), which are also found in cardiac atrium. In normal human plasma, γ-BNP is the predominant molecular form, while the main form in cardiac atrium is BNP-32. These results suggest that biosynthesis and secretion of BNP are augmented in heart disease and that human BNP has a unique processing and metabolic system distinct from that of ANP. © 1992.
引用
收藏
页码:760 / 767
页数:8
相关论文
共 18 条